Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2023
DOI: 10.1016/j.bbcan.2023.189023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2023. Verfasst von Qian Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya…. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Carcinoma, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 186 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The high prevalence of metabolic reprogramming in nasopharyngeal carcinoma (NPC) offers an abundance of potential therapeutic targets. This review delves into the distinct mechanisms underlying metabolic reprogramming in NPC, including enhanced glycolysis, nucleotide synthesis, and lipid metabolism. All of these changes are modulated by Epstein-Barr virus (EBV) infection, hypoxia, and tumor microenvironment. We highlight the role of metabolic reprogramming in the development of NPC resistance to standard therapies, which represents a challenging barrier in treating this malignancy. Furthermore, we dissect the state of the art in therapeutic strategies that target these metabolic changes, evaluating the successes and failures of clinical trials and the strategies to tackle resistance mechanisms. By providing a comprehensive overview of the current knowledge and future directions in this field, this review sets the stage for new therapeutic avenues in NPC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013,…
- The Hormel Institute, University of Minnesota, Austin, MN 55912, USA.
- Early Clinical Trial Center, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, PR China. Electronic address: chenxue@hnca.org.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Q., Bode, A. M., Chen, X., & Luo, X. (2023). Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. https://doi.org/10.1016/j.bbcan.2023.189023
Vancouver
Liu Q, Bode AM, Chen X, Luo X. Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2023. doi:10.1016/j.bbcan.2023.189023
BibTeX
@article{Liu2023,
author = {Liu, Qian and Bode, Ann M and Chen, Xue and Luo, Xiangjian},
title = {Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities},
journal = {Biochimica et Biophysica Acta (BBA) - Reviews on Cancer},
year = {2023},
doi = {10.1016/j.bbcan.2023.189023}
}
EUVIMED